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Summary
Background.— Despite advances in procedures for percutaneous coronary intervention (PCI) and
enhancement of materials and adjunctive therapy, postprocedural mortality remains a possible
adverse outcome after PCI.
Aims.— To assess factors independently associated with in-hospital mortality in patients
referred for PCI.
Methods.— Between January 2004 and December 2005, 4074 PCI were performed in our Uni-
versity Hospital, with 70 deaths registered either during the procedure or during the in-hospital
stay. The 70 patients who died were age- and sex-matched with 70 controls in a case-controlmyocardial
infarction;
Proximal lesion
design study. Clinical and angiographic characteristics at hospital admission were collected from
the patients’ medical ﬁles.
Results.— The cumulative incidence rate for in-hospital mortality was 1.72%. Variables
positively and signiﬁcantly associated with in-hospital mortality were severe renal failure
Abbreviations: CI, conﬁdence interval; COPD, chronic obstructive pulmonary disease; GUSTO, global use of strategies to open
occluded coronary arteries; MDRD, modiﬁcation of diet in renal disease; NSTEMI, non-ST-segment elevation myocardial infarction; OR,
odds ratio; PAD, peripheral artery disease; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction.
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(55.7% in cases versus 12.9% in controls, p < 0.0001), cardiac failure (26.1% versus 10.1%,
p = 0.01), ST-segment elevation myocardial infarction (STEMI) (70.6% versus 31.4%, p < 0.0001),
proximal coronary lesion (72.9% versus 40.0%, p < 0.0001) and angiographically visible thrombus
(14.3% versus 4.3%, p = 0.04). Conversely, history of coronary heart disease, smoking and dys-
lipidemia were less frequent among cases. In multivariable analysis, the adjusted odds ratios
(OR) for in-hospital death were 4.89 (95% conﬁdence interval [CI] 1.96—12.2, p < 0.001) in STEMI
versus non-STEMI, 4.28 (95% CI 1.73—10.6, p < 0.01) in those with a proximal coronary lesion,
and 9.77 (95% CI 3.42—27.9, p < 0.0001) in patients with severe renal failure.
Conclusion.— STEMI, proximal coronary lesion, and renal failure at admission are identiﬁed as
particular settings associated with a higher probability of in-hospital mortality after PCI.
© 2008 Elsevier Masson SAS. All rights reserved.
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Résumé
Contexte.— En dépit des progrès réalisés dans les procédures, l’amélioration du matériel et
des traitements adjuvants, l’angioplastie coronaire évolue encore parfois vers une issue fatale.
Objectifs.— Identiﬁer les facteurs indépendamment associés à la probabilité de décès intra-
hospitalier, chez les patients adressés pour angioplastie.
Méthodes.— De janvier 2004 à décembre 2005, 4074 angioplasties coronaires ont été réalisées
dans notre CHU. Soixante dix décès sont survenus durant la procédure ou le séjour hospitalier.
Les 70 patients décédés ont été appariés sur l’âge et le sexe à 70 témoins. Les caractéristiques
cliniques et angiographiques des patients à l’admission ont été recueillies à partir du dossier
médical.
Résultats.— L’incidence cumulée des décès était de 1,72 %. Les variables associées positive-
ment et signiﬁcativement à la mortalité étaient l’insufﬁsance rénale (55,7 % parmi les cas versus
12,9 % parmi les témoins, p < 0,0001), l’insufﬁsance cardiaque (26,1 % versus 10,1 %, p = 0,01),
le syndrome coronaire aigu avec élévation du segment-ST (SCA-ST+) (70,6 % versus 31,4 %,
p < 0,0001), la présence d’une lésion coronaire proximale (72,9 % versus 40.0 %, p < 0,0001),
d’un thrombus (14,3 % versus 4,3 %, p = 0,04). À l’inverse, coronaropathie préexistante, tabag-
isme et dyslipidémie étaient moins fréquents parmi les cas. En analyse multivariée, les odds
ratios (OR) ajustés de mortalité étaient : OR = 4,89 (intervalle de conﬁance à 95% [1,96—12,2],
p < 0,001) pour les SCA-ST+ comparativement aux SCA sans élévation du segment-ST, OR = 4,28
([1,73—10,6], p < 0,01) en cas de lésion coronaire proximale, OR = 9,77 ([3,42—27,9], p < 0,0001)
en cas d’insufﬁsance rénale sévère.
Conclusion.— Le SCA-ST+, une lésion coronaire proximale et l’insufﬁsance rénale sévère sont
lus é
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ackground
oronary artery disease is one of the most frequent causes
f morbidity and mortality in industrialized countries. Since
ts introduction in 1977, percutaneous coronary intervention
PCI) has developed signiﬁcantly to become the reference
reatment for coronary disease. Improvement in operators’
xperience and in technical materials with, in particular, the
se of new generation coronary stents, has contributed to
he enhancement in the efﬁcacy and safety of the proce-
ures. Advances in PCI have been associated with a reduced
isk of adverse outcomes and have broadened the indications
or the technique. Nevertheless, postprocedural mortality
emains a possible adverse outcome.
Multivariable models have been developed previously
o assess independent determinants of in-hospital mortal-
ty after PCI [1—4]. However, such determinants may vary
ccording to differences in healthcare access, practice pat-
erns and procedural techniques, and may thus differ across
ountries. The aim of this work was to assess factors inde-
endently associated with in-hospital mortality in patients
eferred for PCI.
l
7
f
clevée de décès postangioplastie.
rights reserved.
ethods
tudy population and data collection
etween January 2004 and December 2005, a total of
074 PCI were performed in the Department of Cardiol-
gy of the Toulouse University Hospital (France): 53.5% in
atients presenting with non-ST-segment elevation myocar-
ial infarction (NSTEMI), 31.5% in subjects with ST-segment
levation myocardial infarction (STEMI), and 15.0% in
atients who had elective PCI (for stable angina or silent
schemia). Seventy (1.72%) patients died either during the
rocedure or during the in-hospital stay. For each index case
f death, an age- and sex-matched control was selected,
ho corresponded to the ﬁrst patient with the same sex and
ge (± 4 years) and who underwent a PCI in the Department
f Cardiology and survived the procedure. The study popu-
ation was thus made up of 70 deceased patients (cases) and
0 age- and sex-matched surviving controls.
Data on previous medical conditions, cardiovascular risk
actors, and clinical and angiographic characteristics were
ollected from the patients’ medical ﬁles. In particular,
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tFactors predictive for in-hospital mortality following percut
a history of coronary heart disease (previous acute coro-
nary syndrome, PCI or coronary artery bypass surgery),
vascular disease (peripheral artery disease [PAD], stroke
or transient ischemic attack), cardiac failure, or chronic
obstructive pulmonary disease (COPD) were sought, as well
as the indication for PCI (STEMI, NSTEMI, stable angina or
silent ischemia), the time of the procedure, the clinical pre-
sentation of the patient at admission (height, weight, signs
of cardiogenic shock) and the angiographic characteristics
of the coronary vessels and lesions.
Cardiac failure before PCI (preprocedural cardiac failure)
was deﬁned as a combination of symptoms including dysp-
noea, ankle edema, pulmonary rales, or need for diuretic,
vasodilator or antihypertensive drug treatment. Preproce-
dural cardiogenic shock was deﬁned as the presence of
pulmonary edema with an evidence of hypoperfusion. Kid-
ney function was assessed using the modiﬁcation of diet in
renal disease (MDRD) [5] equation for estimating creatinine
clearance. Severe preprocedural renal failure was assessed
when creatinine clearance was equal to 40mL/min or less
[6]. Proximal coronary lesions included lesions of the prox-
imal segments of the left anterior descending and the left
circumﬂex arteries.
Statistical analysisThe statistical analysis was performed using the SAS soft-
ware package, version 9.1 (SAS Institute Inc., Cary, North
Carolina, USA), based on a case-control study design. The
distribution of qualitative variables was compared between
cases and controls using the chi-square test when appropri-
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Table 1 Clinical characteristics.
Controls (
Women, n (%) 11 (15.7)
Age (years) 72.5 (12.0
Body mass index (kg/m2) 26.4 (4.4)
Previous coronary artery disease, n (%) 26 (37.1)
Previous vascular disease, n (%) 10 (14.3)
Previous cardiac failure, n (%) 1 (1.4)
Previous COPD, n (%) 3 (4.3)
Preprocedural renal failurea, n (%) 9 (12.9)
Smoking, n (%) 43 (61.4)
Hypertension, n (%) 44 (62.9)
Diabetes, n (%) 14 (20.3)
Dyslipidemia, n (%) 37 (54.4)
Indication for PCI, n (%)
STEMI 22 (31.4)
NSTEMI 40 (57.2)
Otherb 8 (11.4)
Preprocedural cardiac failure, n (%) 7 (10.1)
Preprocedural cardiogenic shock, n (%) 2 (2.9)
Time of PCI, n (%)
10.00 pm—6.00 am 9 (13.4)
Results are given as n (percent) or mean (standard deviation).
COPD: chronic obstructive pulmonary disease; PCI: percutaneous c
infarction; NSTEMI: non-ST-segment elevation myocardial infarction.
a Creatinine clearance≤ 40mL/min.
b Other: stable angina or silent ischemia.us coronary intervention 445
te and Fisher’s exact test in case of small numbers. Means
f quantitative variables were compared using Student’s t-
est. Variables associated with the case-control status in
ivariate analysis (p-value below 0.20) were introduced in a
ackward multivariable logistic regression analysis to deter-
ine the variables that were signiﬁcantly and independently
ssociated with the case-control status. Odds ratios (OR) are
iven with 95% conﬁdence intervals (CI). All p-values are
wo-sided.
esults
linical characteristics
ll patients received aspirin (160mg/day) and a single
ntravenous injection of heparin (50UI/kg) as adjunctive
herapies. A coronary stent (drug-eluting or bare metal)
as implanted in 85% of patients. The population was quite
lderly with a mean age of 72.5 and 73.0 years old in con-
rols and cases, respectively, ranging from 33 to 93. The two
roups were predominantly male with a sex ratio of 5.4. The
edian duration of in-hospital stay was four days in both
ases (interquartile range < 1—8) and controls (interquartile
ange 3—6). The clinical characteristics of the cases and con-
rols at hospital admission are shown in Table 1. The two
roups were not signiﬁcantly different in terms of age, sex,
ody mass index, history of vascular (noncoronary) disease,
ypertension, diabetes, cardiac failure and COPD. Further-
ore, no signiﬁcant difference was observed regarding the
ercentage of cases and controls treated during off-hours.
n = 70) Cases (n = 70) p
11 (15.7) 1
) 73.0 (11.8) 0.83
26.6 (4.1) 0.83
14 (20.0) 0.02
6 (8.6) 0.29
2 (2.9) 0.99
2 (2.9) 0.99
39 (55.7) < 0.0001
26 (37.1) < 0.01
34 (48.6) 0.09
20 (28.6) 0.26
22 (31.4) < 0.01
< 0.0001
48 (70.6)
18 (26.5)
2 (2.9)
18 (26.1) 0.01
12(17.1) < 0.01
13 (18.8) 0.39
oronary intervention; STEMI: ST-segment elevation myocardial
446 W. Zouaoui et al.
Table 2 Angiographic characteristics.
Controls (n = 70) Cases (n = 70) p
Coronary status, n (%) 0.12
Single-vessel disease 26 (37.1) 15 (21.4)
Two-vessel disease 23 (32.9) 30 (42.9)
Three-vessel disease 21 (30.0) 25 (35.7)
Left main coronary artery lesion, n (%) 3 (4.3) 7 (10.0) 0.19
Proximal lesion, n (%) 28 (40.0) 51 (72.9) < 0.0001
Thrombus, n (%) 3 (4.3) 10 (14.3) 0.04
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onversely, smokers and patients with a history of coro-
ary heart disease or dyslipidemia were signiﬁcantly more
requent among controls.
Severe preprocedural renal failure was more often
bserved in cases than in controls (55.7% versus 12.9%,
< 0.0001). PCI was performed in a context of an acute
oronary syndrome (STEMI or NSTEMI) in 92.8% of the study
opulation. The distribution of patients presenting with
TEMI, NSTEMI, silent ischemia or stable angina was sig-
iﬁcantly different between cases and controls, with the
roportion of patients with STEMI greater among the cases
p < 0.0001). The proportion of patients with preprocedu-
al clinical presentation of cardiac failure or cardiogenic
hock was also signiﬁcantly higher among cases (26.1% ver-
us 10.1%, p = 0.01 for cardiac failure and 17.1% versus 2.9%,
< 0.01 for cardiogenic shock).
Hemorrhage after PCI occurred in 12 patients (four in
ontrols and eight in cases), among which seven were con-
idered as severe according to the global use of strategies to
pen occluded coronary arteries (GUSTO) classiﬁcation (i.e.
ntracranial hemorrhage or bleeding that caused hemody-
amic compromise and required intervention) [7]. The seven
evere hemorrhages all occurred in the group of cases.
ngiographic data
he angiographic characteristics of the patients are listed
n Table 2. The proportion of patients with lesions of the
eft main coronary artery as well as the distribution of those
ith a single-, two- or three-vessel disease tended to be
ifferent between cases and controls but did not achieve
he signiﬁcant statistical level. An angiographically visible
hrombus was present in 14.3% of the deceased patients,
ut only in 4.3% of the controls (p = 0.04). The lesion was
onsidered as proximal in 72.9% of the cases and in 40.0% of
he controls (p < 0.0001).
ndependent predictors of in-hospital
ortality
n multivariable analysis (Table 3), STEMI, proximal coronary
esion and severe preprocedural renal failure were indepen-
ently associated with a higher probability of in-hospital
ortality, whereas patients who smoked remained at a lower
isk of death. Further adjustments for age and sex did not
igniﬁcantly change these results.
d
h
i
p
i3 (4.3) 0.62
10 (14.3) 0.02
iscussion
ver the past decade, indications for PCI have increased
ramatically, with treated patients now including subjects
ith severe cardiovascular disease, comorbidities and com-
lex lesions. Despite a satisfactory success rate, serious
dverse outcomes can still be observed after PCI, includ-
ng artery dissection, postprocedural chest pain with altered
T-segment or raised biochemical markers of myocardial
ecrosis, postprocedural need for surgery, or in-hospital
eath (with an incidence of 1.1 to 1.7%) [1—4,8]. Previ-
us studies aimed at assessing determinants of mortality
ollowing PCI were conducted mainly in US registries. As
he efﬁcacy of coronary interventions is greatly dependent
n healthcare system organization and access to emer-
ency facilities, especially in the particular setting of acute
oronary syndromes, national data are now needed to inves-
igate such determinants in the French healthcare system.
ur study identiﬁes several adverse conditions associated
ith a higher probability of in-hospital mortality in patients
eferred for PCI.
Age, which was used in our study as a matching crite-
ion between cases and controls, has been shown previously
o be strongly predictive of a high risk of in-hospital mor-
ality [9]. Associated comorbidities have also been related
o an increased risk of death following PCI, in both elderly
nd young patients. In particular, preprocedural renal fail-
re reduces the success rate of PCI and increases the risk
f in-hospital and long-term major acute coronary events.
onsistently, decreased preprocedural creatinine clearance
as a major independent predictor of death in our study.
ubenstein et al. [10] suggested that patients with moder-
te and severe renal failure may actually develop similar
hort- and long-term outcomes. Furthermore, postprocedu-
al renal failure has also been considered as being predictive
f in-hospital mortality [11].
The other comorbidities that have previously been asso-
iated with a poor prognosis after PCI are peripheral artery
isease and COPD. Indeed, patients presenting with a history
f intermittent claudication, angiographic abnormalities of
ower limb arteries, stroke or transient ischemic attack, and
reated with PCI in the context of an acute coronary syn-
rome have poor short- and long-term prognoses [12]. This
as been related to a worse clinical proﬁle but also to an
nsufﬁciently aggressive management. In our study, such a
oor relationship between noncoronary artery disease and
n-hospital mortality was not observed. COPD has been pin-
Factors predictive for in-hospital mortality following percutaneous coronary intervention 447
Table 3 Independent predictors of mortality.
OR: odds ratio; CI: conﬁdence interval; PCI: percutaneous coronary intervention; STEMI: ST-segment elevation myocardial infarction.
*Creatinine clearance≤ 40mL/min.
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pointed in several series as a predictive factor for in-hospital
mortality in patients undergoing surgical revascularization
[13]. However, few studies have looked into its relationship
with PCI. Selvaraj et al. [14] reported an in-hospital mortal-
ity rate of 2.9% in chronic bronchopathic patients versus only
1.2% in those without COPD (p < 0.0001). Patients with COPD
are at high-risk because of more frequent comorbidities,
generally low left ventricular ejection fraction and con-
traindications for beta-blockers. In our study, the number of
patients with COPD was unfortunately too small to provide
sufﬁcient power to conveniently study this parameter.
Patients suffering from a myocardial infarction and pre-
senting with a history of cardiac failure are at very high risk
of a poor outcome after PCI, with a fourfold increased risk of
mortality [15]. The risk is even higher when cardiac failure
develops during the in-hospital phase and is associated with
cardiogenic shock. In our study, preprocedural cardiac fail-
ure was noted in 26.1% of the deceased patients and in 10.1%
of the controls (p = 0.01). However, this signiﬁcant associa-
tion disappeared after adjustment for PCI indication (STEMI,
NSTEMI, stable angina or silent ischemia). A larger cohort
would have allowed a better investigation of the additional
risk associated with acute cardiac failure.
Complex lesions are more frequently associated with
major artery dissections, distal embolisms, occlusion of
smaller vessels and microcirculation alterations (slow ﬂow
and no reﬂow). Wilensky et al. [16] showed that patients
treated for complex coronary lesions have a higher mortality
rate, tend to develop ventricular rhythm disturbances, and
more frequently need surgery despite stent implantation
and powerful antiplatelet therapy based on glycoprotein
IIb/IIIa inhibitors. On the one hand, type C complex lesions,
thrombus, calciﬁcations, and bifurcation lesions have been
independently associated with an increased risk of myocar-
dial infarction and in-hospital death [17]. On the other hand,
w
s
t
n
she presence of a collateral circulation developed in the
eft anterior descending artery territory has been shown to
educe infarct areas and consequently to protect against
ardiogenic shock and in-hospital mortality [18].
In our study, PCI indication was one of strongest determi-
ant of in-hospital mortality. We found a signiﬁcantly worse
rognosis in patients admitted for STEMI, whereas no signiﬁ-
ant difference was observed between patients with NSTEMI
nd those who received elective PCI in a non-emergency
ontext. In the literature, patients with STEMI are consis-
ently at a signiﬁcantly higher risk of in-hospital mortality,
ven after extensive adjustment for confounders. This has
ctually been attributed to infarct size and location rather
han type of myocardial infarction [19]. Indeed, stenoses of
he proximal segment of the left anterior descending artery
re known to be situations at particularly high risk, given
hat restenosis is more common with these lesions. However,
n the current era of drug-eluting stents, the location of the
esion seems to have a smaller impact on prognosis [20].
Surprisingly, in our multivariable analysis, smoking was
igniﬁcantly associated with a lower risk of in-hospital
ortality; history of dyslipidemia also tended to be also
ssociated with a lower risk (p = 0.06) (data not shown). This
s likely to reﬂect the fact that patients with cardiovascu-
ar risk factors tended to be more numerous among those
ho underwent PCI elective. Besides, we cannot exclude
hat patients with cardiovascular risk factors may contact
mergency facilities more quickly and thus have access to
reatment and PCI more promptly than patients who are
ot aware of the risk of cardiovascular disease. Our analysis
as unable to fully explore this issue as samples were too
mall to perform stratiﬁed analyses, in particular stratiﬁca-
ions according to the indication of the procedure (acute or
onacute coronary syndrome). The negative link between
moking and mortality may also be related to the fact
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[48
hat active smokers tended to be younger in the group of
ases than in controls (mean 65.3 years versus 71.4 years,
= 0.05). Since age is a major determinant of mortality, this
ay have biased the relationship between smoking and mor-
ality, and could be responsible, at least in part, for the
bserved negative association between smoking and mor-
ality.
tudy limitations
ecause of a retrospective data collection based on
atients’ medical ﬁles, our results are limited by the fact
hat several potential predictors of mortality could not be
aken into account. For instance, left ventricular ejection
raction was lacking in a signiﬁcant number of the ﬁles
vailable and therefore could not be analyzed. Similarly, it
ould have been interesting to study an indicator of opera-
ors’ experience since it has been shown that mortality rate
ollowing PCI is inversely proportional to the volume of pro-
edures in the centre and the experience of the practitioners
21].
Another limitation of our study lies in its case-control
esign, which does not allow us to draw ﬁrm conclusions on
he causal link between predictors and mortality. Indeed,
ven after careful multivariable adjustment, certain condi-
ions may have been brought out without any causal impact
n mortality.
onclusions
n the era of interventional cardiology, understanding the
ituations and mechanisms that lead to adverse outcomes
fter PCI are of major interest. STEMI, proximal lesions and
reprocedural renal failure were the main predictors of in-
ospital mortality in this sample of French patients referred
or PCI. Prospective data are still needed to better estimate
he risk of adverse outcomes after PCI for a given individual,
n the context of the French healthcare system.
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